Phenotypes of Rapid Cystic Fibrosis Lung Disease Progression during Adolescence and Young Adulthood
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Abstract Rationale Individuals with cystic fibrosis are at risk for prolonged drops in lung function, clinically termed rapid decline, during discreet periods of the disease. Objectives To identify phenotypes of rapid pulmonary decline and determine how these phenotypes are related to patient characteristics. Methods A longitudinal cohort study of patients with cystic fibrosis aged 6–21 years was conducted using the Cystic Fibrosis Foundation Patient Registry. A statistical approach for clustering longitudinal profiles, sparse functional principal components analysis, was used to classify patients into distinct phenotypes by evaluating trajectories of FEV1 decline. Phenotypes were compared with respect to baseline and mortality characteristics. Measurements and Main Results Three distinct phenotypes of rapid decline were identified, corresponding to early, middle, and late timing of maximal FEV1 loss, in the overall cohort (n = 18,387). The majority of variation (first functional principal component, 94%) among patient profiles was characterized by differences in mean longitudinal FEV1 trajectories. Average degree of rapid decline was similar among phenotypes (roughly −3% predicted/yr); however, average timing differed, with early, middle, and late phenotypes experiencing rapid decline at 12.9, 16.3, and 18.5 years of age, respectively. Individuals with the late phenotype had the highest initial FEV1 but experienced the greatest loss of lung function. The early phenotype was more likely to have respiratory infections and acute exacerbations at baseline or to develop them subsequently, compared with other phenotypes. Conclusions By identifying phenotypes and associated risk factors, timing of interventions may be more precisely targeted for subgroups at highest risk of lung function loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987 · cited 2×
“The median (range) number of FEV1 observations per individual patient was 19 (7-55), with a follow-up period of 6.”
BackgroundMethod
Cited by
Prognostication and risk factors for cystic fibrosis via automated machine learning
Alaa, A. M., & van der Schaar, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-29523-2 · Cited by 80
Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progression
Szczesniak, R. D., Su, W., Brokamp, C., Keogh, R. H., Pestian, J. P., Seid, M., Diggle, P. J., & Clancy, J. P. (2020) · Statistics in Medicine · doi:10.1002/sim.8443 · Cited by 30
“A description of the app functionality, including patient selection and generating normative data, and an additional illustration are provided as Supporting Information (Figures S4 and S5 in Data S2).”
BackgroundResultInfluentialSzczesniak, R. D., Brokamp, C., Su, W., Mcphail, G. L., Pestian, J., & Clancy, J. P. (2019) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2018.2878534 · Cited by 15
“Indeed, recent work suggests that, although there are distinct patterns or phenotypes of rapid decline, those individuals with the highest lung function initially are at risk for the most severe declines early in life [8].”
BackgroundSelf-citationCellDrift: inferring perturbation responses in temporally sampled single-cell data
Jin, K., Schnell, D., Li, G., Salomonis, N., Prasath, V. B. S., Szczesniak, R., & Aronow, B. J. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac324 · Cited by 11
“For example, FPCA has been used in the trajectory evaluation of cystic fibrosis progression [34] and monitoring of glucose levels in hyperglycemic patients [35].”
Self-citation
Metadata
- Authors
- Szczesniak, R. D., Li, D., Su, W., Brokamp, C., Pestian, J., Seid, M., & Clancy, J. P.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-08-15
- Volume
- 196
- Issue
- 4
- Pages
- 471-478
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2606932043
- Cited by
- 54
- References
- 2
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenotypes of Rapid Cystic Fibrosis Lung Disease Progression during Adolescence and Young Adulthood. https://app.cochat.ai/papers/10.1164/rccm.201612-2574oc
- The paper
- Szczesniak, R. D., Li, D., Su, W., Brokamp, C., Pestian, J., Seid, M., & Clancy, J. P. (2017). Phenotypes of Rapid Cystic Fibrosis Lung Disease Progression during Adolescence and Young Adulthood. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201612-2574oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.